BioSpace News Archive

Benz R&D is the leading technologically advanced independent supplier of performance materials and manufacturing technology to the IOL industry

- Lambda significantly accelerated viral decline - Viral clearance highly correlated with baseline viral loads - All Lambda-treated patients were below the infectivity threshold by Day 7

Castle Creek Biosciences, Inc, a privately-held, clinical-stage cell and gene therapy company leveraging its proprietary fibroblast technology platform to develop and commercialize innovative personalized

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that the Company will release its third quarter 2020 financial results on Friday, November 6, 2020, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time on November 6, 2020. The financial results and live webcast will be accessible through the Investor Relations section of the

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) (“Titan” or the “Company”) today announced a strategic restructuring designed to position it for future growth. Specifically, the Company plans to:

Regulus Therapeutics Inc . (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the “Company” or “Regulus”), today announced initiation of dosing in its Phase 1b clinical study of RGLS4326 in patients with ADPKD.

Merck KGaA, Darmstadt, Germany , a leading science and technology company, today announced that Dr. Luciano Rossetti, MD, will be retiring as Global Head of Research

Pending FDA approval, Santa Fe BioLabs will be introducing AuriFind TM , a colony/culture classification assay to identify the fungus Candida auris , for which US patent #10662405 was recently granted. This yeast-like fungus is a growing concern

Cellaria, Inc. (Wakefield, MA, USA), a scientific innovator with breakthrough tools for cancer research, has introduced three next generation Pancreatic Cancer cell lines, substantially boosting the value of in vitro methods in the development of more effective therapies. Difficult to detect

On September 23rd, the FDA announced the highest level of alert about benzodiazepines when it required a boxed warning for all of these medications.